Eric Topol on Nostr: The KP.3 variant is taking over in the US, with 2 key mutations beyond JN.1 (F456L ...
The KP.3 variant is taking over in the US, with 2 key mutations beyond JN.1 (F456L and Q493E) at the same time FDA has planned for JN.1 to be the target of the new Covid booster in September. Big mismatch and bad call.
Published at
2024-06-07 14:48:19Event JSON
{
"id": "cdfc7b4801a0ad811e5357cc1e14fac2e20644e3f97ee48685e9e92048c38651",
"pubkey": "5077f486a3f2f72d07e0efd5cb00aa243734739327371edd92d5c63a7b7dfe53",
"created_at": 1717771699,
"kind": 1,
"tags": [
[
"proxy",
"https://mstdn.social/users/erictopol/statuses/112575886113840822",
"activitypub"
]
],
"content": "The KP.3 variant is taking over in the US, with 2 key mutations beyond JN.1 (F456L and Q493E) at the same time FDA has planned for JN.1 to be the target of the new Covid booster in September. Big mismatch and bad call.\n\nhttps://media.mstdn.social/media_attachments/files/112/575/885/893/846/297/original/8bd206fd5c1aa22c.png",
"sig": "678c59859cad195a5692c7fa52f041e958fec99f92934181e482edf00e310506815541ba8e536048289717aa3e3d36b03c17682ddf4144f8f971ca64f039ddc1"
}
